Tumors fall into 1 of 5 grade groups based on what pathologic findings indicate about prognosis.
Eric M. Wallen, MD, Professor of Urology and Urology Residency Program Director at the University of North Carolina Chapel Hill, uses telemedicine and shares his experience.
Sleep apnea may be a novel risk factor for chronic kidney disease (CKD), a new Taiwanese study suggests.
Roxadustat, an investigational oral drug, is well tolerated and can maintain hemoglobin (Hb) levels for up to 19 weeks in patients with end-stage renal disease (ESRD) and anemia.
Patients who undergo radical prostatectomy (RP) have unrealistic expectations about their sexual function after the operation, new study findings reveal.
Many small practices fall short on requirements because they do not have the resources to comply.
Treatment with recombinant human erythropoietin (rHuEPO) in patients with chronic kidney disease (CKD) but not on dialysis corrects anemia, reduces the need for blood transfusions, and improves quality of life and exercise capacity, researchers concluded from a systematic review.
A combination of external beam radiation therapy (EBRT) and brachytherapy provides a modest survival benefit compared with brachytherapy alone for patients with intermediate prostate cancer (PCa), a new study finds.
Appointment schedules should reflect physicians' work style and patient demands.
Increased clinical research has been focused on the sodium-glucose co-transporter 2 (SGLT-2) inhibitors for the management of type 2 diabetes.
Access our job board to view over 1,000 job openings throughout the US.
Tell us about your social media habits for a chance to win a free gift card.
Access information and support materials for Xtandi that can help your practice and patients with metastatic castration-resistant prostate cancer.